The transgenic construct contains a hemagluttinin (HA) tagged mutant mouse Sgk1 sequence under the control of the cardiac-specific Myh6 promoter. The KD mutation replaces a lysine at residue 141 (published as 127) for a methionine (K141M), inactivating the kinase (kinase dead - KD). (J:210069)